Beyond the Report: a Dynamic View of UK Cell and Gene Therapy Clinical Trials
The UK is undeniably a global powerhouse for Cell & Gene Therapy (CGT). This position is built on a foundation of transparency and world-class data aggregation, led by the incredible work of the UK Cell & Gene Therapy Catapult. Their annual Clinical Trial Database is the Gold Standard for our industry - a massive undertaking of cleaning, verifying, and organizing the pulse of UK innovation.
At Lonrú Studios™, we believe that when you have such a high-quality dataset, the next step is to make it insightful.
To complement the Catapult’s exhaustive YE 2025 report, we have built a VantagePoint Insights™ Dashboard. Our goal isn't to replace the report, but to provide a dynamic digital companion that allows leaders to interact with this vital data in real-time.
Building on a World-Class Foundation
By taking the Catapult’s meticulously curated data and applying our VantagePoint™ logic, we’ve created a tool that allows you to pivot from a macro view of the market to granular trial details in seconds. We are shifting the experience from Reading to Exploring.
What’s Inside the VantagePoint Insights™ Dashboard?
We’ve focused on two primary strategic visualizations to help you navigate the 2025 landscape:
The Pipeline Maturity Matrix: This view honors the sheer volume of UK trials by grouping them by Therapeutic Area and then stacking them by phase. It allows you to see instantly where the market is maturing - for example, identifying how Ophthalmology is successfully pushing a high percentage of candidates into late-stage Phase III delivery.
The Tech Dominance Treemap: In collaboration with the Catapult’s classification of modalities, this treemap visualizes the Plumbing of the industry. You can see the massive footprint of AAV and Lentiviral vectors, but also identify the emerging pockets where non-viral delivery is beginning to gain traction.
Experience Innovation Illuminated
We invite you to explore the UK’s clinical trial data below. Use the filters to find specific sponsors, therapeutic niches, or technology types. This is the UK CGT landscape viewed with VantagePoint Insights™: vibrant, interactive, and structured for strategy.
© 2026 Lonrú Consulting Ltd. | Data sourced from the UK CGT Catapult | Powered by Lonrú Studios™
